Building Stronger Partnerships & Celebrating Success
KBW Financial Staffing & Recruiting is proud to deepen our specialized partnerships with growing firms across the life sciences sector, supporting organizations at the forefront of innovation and discovery. Across life sciences organizations supporting R&D, manufacturing, and distribution, spanning therapeutics, vaccines, diagnostics, and more, we help connect growing companies with the financial and accounting talent that fuels confident growth.
Through our close collaboration with Alexander Technology Group, led by John Whelan, Managing Director in Portsmouth, NH, and co-founder and board member of NH Life Sciences, we continue to strengthen our presence within the region’s expanding life sciences ecosystem. We’re also excited to highlight NH Life Sciences’ newly refreshed website, a valuable hub for news, resources, and insights shaping the future of this thriving sector.
Plus, a big congratulations to our employees who earned the 2026 Partner’s Trip to Aruba! Your dedication does not go unnoticed – we’re excited to celebrate you!
Life Sciences Spotlight: Building the Teams Powering New Hampshire’s Innovation
KBW Financial Staffing & Recruiting is proud to deepen our specialized partnership with growing firms across the life sciences sector.
Our partners in life science include, but are not limited to, those involved in R&D, manufacturing, and distribution of therapeutic drugs, vaccines, medical devices, diagnostics, and agricultural products. Through our close collaboration with Alexander Technology Group, led by John Whelan, Managing Director in Portsmouth, NH, and one of the co-founders and board members of NH Life Sciences, we help connect innovative companies with the financial and accounting talent they need to scale with confidence.
We’re excited to share NH Life Sciences’ newly refreshed website as a hub for news, resources, and the expanding life sciences ecosystem here in New Hampshire.
KBW and ATG are here to help you build the team behind the breakthrough!
To learn more about how we are supporting many of the best companies throughout Greater Boston and New Hampshire in life sciences, please contact us today.
Congratulations to our 2026 Partners Trip qualifiers heading to Aruba in 2026! 🌴
These outstanding team members have gone above and beyond, demonstrating dedication and excellence throughout the year. We can’t wait to celebrate you!
This Week’s Featured Jobs find your next career move
Accounting Policy Manager – Boston, MA | $128k-$166k/year
Wealth Tax Strategist – Winchester, MA | $125k-$140k/year
Operations Business Manager – Waltham, MA | $55-$65/hour
Staff Accountant – Nashua, NH | $60k-$65k/year
Accounting Manager – Portland, ME | $120k-$140k/year
Controller – Rochester, NH | $130k-$150k/year
Financial Analyst – Lewiston, ME | $70k-$85k/year
Senior Financial Analyst – York, ME | $99k-$120k/year
Senior Tax Associate – Exeter, NH | $120k-$130k/year
Senior Tax Manager – Newington, NH | $150k-$170k/year
Sr. Accountant – Portsmouth, NH | $35-$50/hour
Sr. Financial Analyst – Saco, ME | $115k-$125k/year
Sr. FP&A – Woburn, MA | $110k-$130k/year
IPO Momentum: what 2025’s rebound signals for 2026
The IPO market showed renewed strength in 2025, raising questions about whether 2026 could mark a full-scale comeback. Nearly two dozen companies valued at more than $1 billion went public during the year, a sharp increase from just nine in 2024. Combined valuations for these billion-dollar-plus listings more than doubled year over year, reaching $125 billion, according to Crunchbase.
Overall IPO activity also picked up meaningfully. In total, 202 IPOs raised $44 billion in 2025, compared with 150 offerings that raised $29.6 billion the prior year, data from Renaissance Capital show. Momentum may continue building as several high-profile private companies, including OpenAI, Anthropic, and SpaceX, line up advisors for potential public debuts. Each is expected to qualify as a “mega-IPO,” with valuations exceeding $100 billion at listing.
Market conditions appear increasingly supportive. PwC points to moderating inflation, expected interest rate cuts, and a growing backlog of IPO-ready companies as key drivers for increased activity. Blackstone President Jonathan Gray echoed that optimism, noting that the firm has assembled one of its largest IPO pipelines to date as public markets become more liquid and receptive.
Early signs in 2026 suggest a steady start. EquipmentShare led the year so far with a $747 million IPO on January 22, achieving a $6.7 billion valuation. Performance post-IPO has been mixed, however. Crypto infrastructure firm BitGo raised $213 million in its January debut but saw its stock fall 19% shortly after pricing.
SPACs also played a major role in the rebound. In 2025, 62% of U.S. companies that went public did so via special-purpose acquisition companies, a trend that could extend into 2026. Observers note that this wave of SPACs appears more disciplined, with smaller deals, more realistic valuations, and stronger sponsor alignment. So far this month alone, SPAC IPOs have raised more than $2 billion, signaling continued investor interest in the structure.
Connecting Talent & Opportunity: KBW Financial Staffing & Recruiting is ready to help you grow!
